Efficacy of SIGMAR1-based therapy in the early treatment of confirmed mild symptomatic COVID-19 patients

Grau, SantiagoVela, José MiguelGurt, AlbaBarceló Vidal, JaimeOjeda, FabiolaLópez, IagoGómez García, LauraLoza García, María IsabelMartín García, ElenaMaldonado, RafaelMonfort, Jordi2026-01-202026-01-202024-02Santiago Grau, José Miguel Vela, Alba Gurt, Jaime Barceló-Vidal, Fabiola Ojeda, Iago López, Laura Gómez-García, María Isabel Loza, Elena Martín-García, Rafael Maldonado, Jordi Monfort, Efficacy of SIGMAR1-based therapy in the early treatment of confirmed mild symptomatic COVID-19 patients, Journal of Infection, Volume 88, Issue 2, 2024, Pages 187-190, ISSN 0163-4453, https://doi.org/10.1016/j.jinf.2023.11.008https://hdl.handle.net/10347/45285engAttribution-NonCommercial-NoDerivatives 4.0 Internationalhttp://creativecommons.org/licenses/by-nc-nd/4.0/SIGMAR1-based therapyCOVID-19TreatmentEfficacy of SIGMAR1-based therapy in the early treatment of confirmed mild symptomatic COVID-19 patientsjournal article10.1016/j.jinf.2023.11.0081532-2742open access